Accueil   Diary - News   All news Imaxio and AJ Biologics announce the execution of a collaboration agreement to extend the commercialisation of Imaxio’s leptospirosis vaccine in Malaysia

Imaxio and AJ Biologics announce the execution of a collaboration agreement to extend the commercialisation of Imaxio’s leptospirosis vaccine in Malaysia

IMAXIO NEWSLETTERImaxio, a biotech company specialising in immunology, announces today the execution of a license agreement with AJ Biologics, a Malaysian company dedicated to vaccine manufacturing and commercialization, as part of the company’s strategy to extend the distribution of Imaxio’s leptospirosis vaccine in Malaysia.

Read the press release